RxSight, Inc.: MILLENNIUM MANAGEMENT LLC discloses a stake of more than 5% (Schedule 13G)

Millennium Management LLC disclosed a stake exceeding 5% in RxSight, Inc. via a Schedule 13G filing with the SEC (accession 0001104659-26-125358). The position makes the hedge fund a major shareholder in the ophthalmic medical device maker, whose adjustable intraocular lens technology targets cataract surgery patients. The 13G designation signals a passive investment rather than an activist campaign, though the exact share count and stake value were not specified in the filing summary. Investors will watch for further 13G amendments or 13D filings that could indicate a shift toward active engagement, as well as any changes in Millennium's position in upcoming quarterly disclosures.